Tyr28
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr28  -  RAD9A (human)

Site Information
SRIGDELyLEPLEDG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447825

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
Abl (human) ( 1 )
Kinases, in vitro:
Abl (human) ( 1 )
Treatments:
cytarabine ( 1 )

Downstream Regulation
Effects of modification on RAD9A:
molecular association, regulation ( 1 )
Effects of modification on biological processes:
apoptosis, induced ( 1 )
Induce interaction with:
Bcl-xL (human) ( 1 )

References 

1

Yoshida K, Komatsu K, Wang HG, Kufe D (2002) c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage. Mol Cell Biol 22, 3292-300
11971963   Curated Info